PITX2 and head and neck squamous cell carcinoma: The robust prognostic performance of PITX2 as biomarker in HNSCC is further corroborated, since different CpG-sites were analyzed in the present study, hereby demonstrating that the prognostic value is not only limited to the previously published CpG-sites [16].